The 22 references in paper A. Tolkushin G., N. Pogudina L., А. Толкушин Г., Н. Погудина Л. (2018) “Фармакоэкономический анализ применения лекарственного препарата белимумаб на фоне стандартной терапии системной красной волчанки // Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus” / spz:neicon:pharmacoeconomics:y:2018:i:3:p:23-37

1
Podchernyaeva N. S., Solntseva O. A., Soboleva M. K., Shcherbakova M. Yu. Pediatricheskaya farmakologiya (in Russian).
(check this in PDF content)
2
06; 3 (6): 21-28. 2. Federal clinical guidelines for the diagnosis and treatment of systemic lupus erythematosus. Association of rheumatologists of Russia [Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu sistemnoy krasnoy volchanki. Assotsiatsiya revmatologov Rossii (in Russian)]. 2015.
(check this in PDF content)
3
Nasonov e. L., Reshetnyak T. M., Denisov L. N., Stanislav M. L., Solov’ev S. K. Nauchno-prakticheskaya revmatologiya. 2012; 54 (5): 13-19.
(check this in PDF content)
4
Chirkin A. A., Okorokov A. N., Goncharik I. I. Diagnostic guide of the therapist [Diagnosticheskiy spravochnik terapevta (in Russian)]. 1991.
(check this in PDF content)
5
Bruce I. N., O’Keeffe A. G., Farewell V. et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis. 2015 Sep; 74 (9): 1706-13. DOI: 10.1136/annrheumdis-2013-205171.
(check this in PDF content)
6
Decree of the Government of the Russian Federation of December 8, 2017 No. 1492 “On the Program of State Guarantees of Free Medical Assistance to Citizens for 2018 and for the Planning Period of 2019 and 2020” (in Russian).
(check this in PDF content)
7
Yagudina R. I., Kulikov A. YU., Protsenko M. V. FARMAkoekoNoMIkA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAkoekoNoMIkA. Modern pharmacoeconomics and pharmacoepidemiology (in Russian). 2009; 3: 80.
(check this in PDF content)
8
Yagudina R. I., Serpik V. G. Farmakoekonomika: teoriya i praktika. 2016; 4 (2): 5-9.
(check this in PDF content)
9
Ivahnenko O. I., Avksent’eva M.V., Maksimova L. V. Meditsinskie tekhnologii. otsenka i vybor. 2013; (1): 29-35.
(check this in PDF content)
10
Navarra S. V., Guzman R. M., Gallacher A. e. et al., for the BLISS-52 Study Group. efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebocontrolled, phase 3 trial. Lancet. 2011; 377: 721-31.
(check this in PDF content)
11
Bruce I. N., Urowitz M., van Vollenhoven R., Aranow C. et al. Long-term organ damage accrual and safety in patients with SLe treated with belimumab plus standard of care. Lupus. 2016 Jun; 25 (7): 699-709. DOI: 10.1177/0961203315625119.
(check this in PDF content)
12
Jönsen A., Hjalte F., Willim M., Carlsson K. S. et al. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Semin Arthritis Rheum. 2016 Jun; 45 (6): 684-90. DOI: 10.1016/j. semarthrit.2015.11.013.
(check this in PDF content)
13
Decree of the Government of the Russian Federation of December 8, 2017 No. 1492 “On the Program of State Guarantees of Free Medical Assistance to Citizens for 2018 and for the Planning Period of 2019 and 2020” (in Russian).
(check this in PDF content)
14
Aseeva e. A., Solov’ev S. K., Klyukvina N. G., Popkova T. V. et al. Nauchno-prakticheskaya revmatologiya. 2016; 54 (4): 404-411. https:// doi.org/10.14412/1995-4484-2016-404-411.
(check this in PDF content)
15
Sigidin Ya. A. Work ability of patients with systemic lupus erythematosus [Trudosposobnost’ bol’nyh pri sistemnoy krasnoy volchanke (in Russian)]. [electronic resource]. URL: http://medbe.ru/ materials/sistemnaya-krasnaya-volchanka-skv/trudosposobnostbolnykh-pri-sistemnoy-krasnoy-volchanke/. Accessed: 01.03.2018.
(check this in PDF content)
16
Sigidin Ya. A., Guseva N. G., Ivanova M. M. Systemic lupus erythematosus. Rehabilitation of patients (in Russian). [electronic resource]. URL: http://medbe.ru/materials/sistemnaya-krasnayavolchanka-skv/sistemnaya-krasnaya-volchanka-reabilitatsiyabolnykh/. Accessed: 01.03.2018.
(check this in PDF content)
17
Rosstat: The report “Social and economic Situation of Russia” for 2017 is the final one (in Russian). [electronic resource]. URL: https://nangs. org/analytics/rosstat-doklad-sotsialno-ekonomicheskoe-polozhenie-rossiiza-2017-god-itogovyj-onlajn-pdf. Accessed: 01.03.2018.
(check this in PDF content)
18
Manzi S., Sanchez-Guerrero J., Merrill J. T. et al. effects of belimumab, a B lymphocyte stimulator-specigic inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann Rheum Dis. 2012; 71: 1833-1838. DOI: 10.1136/annrheumdis-2011-200831.
(check this in PDF content)
19
Vollenhoven R. F., Petri M. A., Cervera R., Roth D. A., Ji B. N., Kleoudis C. S., Zhong Z. J., Freimuth W. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann Rheum Dis. 2012 Aug; 71 (8): 1343-9. DOI: 10.1136/annrheumdis-2011-200937.
(check this in PDF content)
20
Aseeva e.A., Soloviev S.K., Mesnyankina A.A., Reshetnyak T.M., Lopatina N.e., Glukhova S.I., Nasonov e.L. Results of an observational prospective study of the efficacy and safety of belimumab (Benlysta®) in systemic lupus erythematosus in real clinical practice. Rheumatology Science and Practice. 2016; 54 (1): 31-37. (In Russian). https://doi. org/10.14412/1995-4484-2016-31-37. [electronic resource] URL: https://rsp.imaress.net/rsp/article/view/2166. Accessed: 01.03.2018.
(check this in PDF content)
21
Gladman D. D., Urowitz M. B., Rahman P., Ibañez D., Tam L. S. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol. 2003 Sep; 30 (9): 1955-9.
(check this in PDF content)
22
Tarasova I. A., Ivanova M. M. Nauchno-prakticheskaya revmatologiya (in Russian). 2003; 2. [electronic resource]. URL: https://rsp. ima-press.net/rsp/article/view/907/599. Accessed: 01.03.2018. 17. Росстат: Доклад «Социально-экономическое положение России» за 2017 год – итоговый. [Электронный ресурс]. URL: https://nangs.
(check this in PDF content)